Case reportRepositioning and follow-up of intralenticular dexamethasone implantMunteanu, Mihnea MD, PhD*; Rosca, Cosmin MD, PhD Author Information From the Department of Ophthalmology (Munteanu), Victor Babeş University of Medicine and Pharmacy, Timişoara and the Optilens Clinic of Ophthalmology (Rosca), Cluj-Napoca, Romania *Corresponding author: Mihnea Munteanu, MD, PhD, Victor Babeş University of Medicine and Pharmacy, Piata E. Murgu 2, 300041, Timişoara, Romania. E-mail: [email protected] Submitted January 7, 2013; revised and accepted March 13, 2013.Figure: No Caption available.First author: Mihnea Munteanu, MD, PhD University of Medicine and Pharmacy, Timişoara, Romania Journal of Cataract & Refractive Surgery 39(8):p 1271-1274, August 2013. | DOI: 10.1016/j.jcrs.2013.06.003 Buy Metrics Abstract We report the case of a 54-year-old man who attended our emergency department complaining of severe floaters and decreased vision in his right eye. Seven days earlier, a dexamethasone intravitreal implant (Oxurdex) had been placed for a noninfectious posterior uveitis. Slitlamp examination showed the implant had penetrated the posterior lens capsule and was lodged in the posterior cortex of the lens; a posterior cortical cataract developed subsequently. Removal of the cataract, repositioning of the implant to the posterior segment, and the postoperative course are described. To our knowledge, this is the first report of the repositioning of an intralenticular dexamethasone intravitreal implant. Financial Disclosure Neither author has a financial or proprietary interest in any material or method mentioned. © 2013 by Lippincott Williams & Wilkins, Inc.